Goldman Sachs
RGEN icon

Goldman Sachs’s Repligen RGEN Stock Holding History

Goldman Sachs’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-48,900
Closed -$1.31M – 7207
2016
Q1 		$1.31M Sell
48,900
-7,600
-13% -$186K ﹤0.01% 3847
2015
Q4 		$1.6M Sell
56,500
-8,500
-13% -$245K ﹤0.01% 3836
2015
Q3 		$1.81M Buy
65,000
+15,000
+30% +$542K ﹤0.01% 3904
2015
Q2 		$2.06M Hold
50,000
– – ﹤0.01% 3800
2015
Q1 		$1.52M Buy
+50,000
New +$1.3M ﹤0.01% 4050

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Goldman Sachs's RGEN Position: Q1 2026 in Review

Goldman Sachs increased its Repligen (RGEN) stake by 121% in Q1 2026, buying an estimated $49.7M and bringing the position to 651,347 shares worth $76.7M. The position accounts for 0.01% of the portfolio, ranked #1232.

Goldman Sachs first reported a position in RGEN in Q4 2013 and has held it in 50 quarters since. The position peaked at $103M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Goldman Sachs held 651,347 shares of Repligen worth $76.7M as of Q1 2026.
  • Goldman Sachs bought 356,076 Repligen shares in Q1 2026, an estimated $49.7M.
  • Repligen made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1232 holding.
  • Goldman Sachs first reported a position in Repligen in Q4 2013 and has held it in 50 quarters since.
  • Goldman Sachs's Repligen position peaked at $103M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.